Back to results
CompletedPhase 4

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

NCT05677334

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China

View on ClinicalTrials.gov
Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM — TrialFind